Happy Diwali
from all of us at RetailBonds
CRISIL · 2026-06-22
CRISIL places Viridis Biopharma Private Limited on rating watch — 22 Jun 2026
CRISIL placed on watch Viridis Biopharma Private Limited on 2026-06-22, rating BB+ with a Stable outlook. No other actions on file yet.
CRISIL's published heading: “Rating migrated to 'Crisil BB+ / Stable'”
| Entity (per CRISIL heading) | Viridis Biopharma Private Limited · issuer page |
| Action | Watch |
| Rating | BB+ |
| Outlook | Stable |
| Action date | 2026-06-22 |
| Agency | CRISIL |
| Source | CRISIL rating rationale ↗ |
About this page: This page restates a rating action as published by CRISIL, a SEBI-registered credit rating agency. The rating and any outlook are the agency's opinion, not RetailBonds.in's, and nothing here is investment advice or a view on what the action means for any investor. Refer to the agency's own rationale document for the full reasoning. See our methodology and full disclaimer.